Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Latest Aleve PM Copy Could Have 180-Day Exclusivity From More Competition

Aug 26 2019

• By Malcolm Spicer

Apotex exterior

Related Content

<em>Aleve PM</em> Enters Nighttime Pain-Relief Market After 160-Count Label Approved

Sep 22 2014

US FDA’s First Competitive Generic Therapy Approval Comes With A Twist

Aug 10 2018

Monograph Reform Legislation In Play As FDA, OTC Industry Get Real On Changes

May 23 2019

GAO Report Casts Shade On Sunscreen Ingredients' Chances With FDA

Nov 21 2017

Related Companies

Apotex Inc.

Bayer AG

Amneal Pharmaceuticals, Inc.

Perrigo Company PLC

Additional Topics

Canada United States OTC Drugs Drug Approval Standards FDA Business Strategies Advertising, Marketing & Sales Commercial Companies Innovation Ingredients Manufacturing Policy Prescription To OTC Switch Regulation Consumer

More from Canada

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window